IMA203CD8 is a second-generation PRAME cell therapy with enhanced pharmacology in ongoing Phase 1a dose escalationManageable tolerability across ...

Detailed price information for Fate Therapeutics (FATE-Q) from The Globe and Mail including charting and trades.

In multiple myeloma, plasma cells proliferate uncontrollably in the bone marrow, disrupting the growth of healthy blood-forming cells. If the disease ...

The U.S. FDA assigned a target action date of April 8, 2026PRINCETON, N.J.--(BUSINESS WIRE)--$BMY #FDA--Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA ...

A combination of missed prevention opportunities and health inequalities can result in the early deaths of people living with ...

A mother ages into illness, a father suffers from a sudden disability, and you’re the only one who can house your loved ones ...

OverviewThe global dental soft-tissue regeneration market is poised to grow steadily at a CAGR of nearly 7% during the ...

An Institute for Value-Based Medicine ® event held in New Haven, Connecticut, on October 30, 2025, brought together a diverse ...

Discover Vor BiopharmaVor Biopharma Inc.'s potential with telitacicept amid funding challenges and market risks. Click for ...

POTS (Postural Orthostatic Tachycardia Syndrome) represents a mechanical failure of blood flow, distinct from standard heart ...

U.S. Senate candidate Mike Rogers has assembled a campaign team of extremist pastors and activists who have long opposed ...

Heel pain (calcaneodynia) is a symptom that almost everyone experiences at some point. This is especially true after a long ...